Upadacitinib in Asian inflammatory bowel disease practice: encouraging real-world efficacy

Enriched recordOpen access

Eun Soo Kim

Abstract

No public abstract is available from the verified source records.

Authors

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

pubmed

Confidence 98%

europepmc

Confidence 96%

unpaywall

Confidence 95%

doaj

Confidence 92%

datacite

Confidence 0%

Referenced works

Real-world effectiveness and safety of upadacitinib in Korean patients with inflammatory bowel disease: a single-center retrospective study

2026 · 0 citations

No local citing links have been materialized yet.

10.1053/j.gastro.2020.12.031

10.1056/nejmoa2212728

10.5217/ir.2025.00235

10.5217/ir.2025.00096

10.5217/ir.2025.00166

Unresolved referenced work

2025

No additional external references are available.